CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Curanex Pharmaceuticals Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.92+0.30 (+6.49%)
Close on Oct 19, 2026
- Market cap
- $139.55M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Curanex Pharmaceuticals's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jun Liu | CEO and President, Director, 10% owner | 10,524,560 | 33.56% | Sep 2, 2025 |
| Huijuan Zhong | Chief Science Officer, Director | – | – | Sep 2, 2025 |
| Ning Zhang | Chief Technology Officer | – | – | Sep 2, 2025 |
| Dian Ying Jing | Secretary, 10% owner | 4,651,000 | 14.83% | Sep 2, 2025 |
| Liqin Xie | Chief Operating Officer | – | – | Sep 2, 2025 |
| Xiaohui Hao | Director | – | – | Sep 2, 2025 |
| Yong Yan | Director | – | – | Sep 2, 2025 |
| Helen Hong Hsu | Director | – | – | Sep 2, 2025 |
| Chang Liu | 10% owner | 7,982,220 | 25.45% | Sep 2, 2025 |